secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2023-06-22T23:59:59+00:00
Accession:  0001104659-23-073836
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Hepion Pharma stockholders elect all director nominees, ratify BDO, approve equity plan, pass say-on-pay
--------------------------------------------------------------------------------

- All seven director nominees elected; votes For ranged from 15.7M (Jacob) to 20.7M (Wijngaard).
- Ratification of BDO USA as auditors passed with 32.5M For, 8.3M Against, 0.8M abstain.
- 2023 Omnibus Equity Incentive Plan approved with 14.4M For, 12.0M Against, 0.3M abstain.
- Advisory say-on-pay proposal passed with 14.2M For, 12.2M Against, 0.4M abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000110465923073836/0001104659-23-073836-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000110465923073836/tm2319442d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-073836

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer